Deficiency in Nrf2 transcription factor decreases adipose tissue mass and hepatic lipid accumulation in

Jialin Xu1, Ajay C Donepudi, Vijay R More

  • 1Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, Rhode Island, USA; Institute of Biochemistry and Molecular Biology, College of Life and Health Sciences, Northeastern University, Shenyang, People's Republic of China.

Abstract

Insights

Nrf2 deficiency in obese mice reduced fat and liver lipids but worsened insulin resistance and dyslipidemia. This highlights Nrf2

Area of Science:

  • Metabolic research
  • Molecular biology
  • Obesity and diabetes research

Background:

  • Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor regulating antioxidant and detoxification genes.
  • Its role in metabolic dysregulation, particularly in obesity and type 2 diabetes, remains complex and requires further elucidation.

Purpose of the Study:

  • To investigate the impact of Nrf2 deficiency on insulin resistance and lipid accumulation in the liver and white adipose tissue of obese mice.

Main Methods:

  • Generation of obese Nrf2-deficient (OB-Nrf2KO) mice using the Lep(ob/ob) model.
  • Assessment of obesity and type 2 diabetes pathogenesis in wild-type, Nrf2-deficient, obese, and obese Nrf2-deficient mice.
  • Determination of hepatic lipid content, clearance, and very low-density lipoprotein (VLDL) secretion in OB and OB-Nrf2KO mice.

Main Results:

  • OB-Nrf2KO mice showed reduced white adipose tissue mass and suppressed adipogenic/lipogenic gene expression compared to obese mice.
  • Nrf2 deficiency exacerbated hyperglycemia and reduced insulin-stimulated Akt phosphorylation.
  • In obese mice, Nrf2 deficiency decreased hepatic lipid accumulation but enhanced VLDL secretion, leading to dyslipidemia (increased triglycerides, decreased HDL-cholesterol).

Conclusions:

  • Nrf2 deficiency in obese mice reduced adipose tissue and hepatic lipid accumulation but induced insulin resistance and dyslipidemia.
  • Nrf2 plays a dual role in metabolic dysregulation, promoting lipid accumulation in lean conditions but mitigating it in obesity while potentially impairing glucose homeostasis.